Trevi Therapeutics, Inc.
USD13.50
-0.45 (-3.23%)
CEO
Jennifer L. Good
IPO Date
2019-05-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$13.92
Prev. Close
$13.95
Day Low
$13.42
Day High
$13.95
52W Low
$5.38
52W High
$16.12
Market Cap
$1.92B
Volume
0.93M
| 35,000 |
| $10.56 |
| 20 Feb 2026 | SCIASCIA THOMAS | Chief Scientific Officer | A-Award | Acquired | 85,000 | $10.56 |
| 20 Feb 2026 | GOOD JENNIFER L | director, officer: President & CEO | A-Award | Acquired | 675,000 | $10.56 |
| 20 Feb 2026 | Simon Farrell | Chief Commercial Officer | A-Award | Acquired | 160,000 | $10.56 |
| 13 Feb 2026 | SANDELL SCOTT D | 10 percent owner | Disposed | 0 | $0.00 |
| 13 Feb 2026 | Florence Anthony A. Jr. | 10 percent owner | Disposed | 0 | $0.00 |
| 13 Feb 2026 | Florence Anthony A. Jr. | 10 percent owner | X-InTheMoney | Disposed | 1,851,852 | $1.37 |
| 13 Feb 2026 | SANDELL SCOTT D | 10 percent owner | X-InTheMoney | Disposed | 1,851,852 | $1.37 |
| 13 Feb 2026 | Behbahani Ali | 10 percent owner | X-InTheMoney | Disposed | 1,851,852 | $1.37 |